XML 110 R85.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 29, 2013
Sep. 30, 2012
Jul. 01, 2012
Sep. 29, 2013
Sep. 30, 2012
Schedule of Condensed Consolidating Statement of Operations [Line Items]          
Net revenues $ 413,796 $ 368,054   $ 1,245,732 $ 1,131,953
Cost of goods sold 209,804 187,487   631,730 582,908
Gross profit 203,992 180,567   614,002 549,045
Selling, general and administrative expenses 115,228 114,878   358,431 332,965
Research and development expenses 15,638 14,760   47,169 40,015
Goodwill impairment     332,000   332,128
Restructuring and other impairment charges 7,084 1,088   29,205 84
(Gain) loss on sales of businesses and assets         (332)
Income (loss) from continuing operations before interest and taxes 66,042 49,841   179,197 (155,815)
Interest expense 13,948 18,493   42,566 54,944
Interest income (144) (340)   (458) (1,324)
Loss on extinguishments of debt 1,250     1,250  
Income (loss) from continuing operations before taxes 50,988 31,688   135,839 (209,435)
Taxes (benefit) on income (loss) from continuing operations 5,209 7,237   18,958 2,961
Income (loss) from continuing operations 45,779 24,451   116,881 (212,396)
Operating income (loss) from discontinued operations 38 (831)   (1,746) (7,951)
Taxes (benefit) on income (loss) from discontinued operations (991) [1] 1,690 [1]   (1,547) [1] (1,668) [1]
Income (loss) from discontinued operations 1,029 (2,521)   (199) (6,283)
Net income (loss) 46,808 21,930   116,682 (218,679)
Less: Income from continuing operations attributable to noncontrolling interests 234 188   629 701
Net income (loss) attributable to common shareholders 46,574 21,742   116,053 (219,380)
Other comprehensive income attributable to common shareholders 24,375 49,428   (6,335) 20,525
Comprehensive income (loss) attributable to common shareholders 70,949 71,170   109,718 (198,855)
Parent Company
         
Schedule of Condensed Consolidating Statement of Operations [Line Items]          
Selling, general and administrative expenses 14,088 11,114   45,915 39,683
Restructuring and other impairment charges 828     828  
(Gain) loss on sales of businesses and assets   1     (116,193)
Income (loss) from continuing operations before interest and taxes (14,916) (11,115)   (46,743) 76,510
Interest expense 33,492 36,105   100,682 109,206
Interest income 3 (107)     (360)
Loss on extinguishments of debt 1,250     1,250  
Income (loss) from continuing operations before taxes (49,661) (47,113)   (148,675) (32,336)
Taxes (benefit) on income (loss) from continuing operations (18,446) (16,624)   (54,192) (51,685)
Equity in net income of consolidated subsidiaries 76,448 52,627   210,701 (238,187)
Income (loss) from continuing operations 45,233 22,138   116,218 (218,838)
Operating income (loss) from discontinued operations 364 (1,089)   (1,788) (1,180)
Taxes (benefit) on income (loss) from discontinued operations (977) (693)   (1,623) (638)
Income (loss) from discontinued operations 1,341 (396)   (165) (542)
Net income (loss) 46,574 21,742   116,053 (219,380)
Net income (loss) attributable to common shareholders 46,574 21,742   116,053 (219,380)
Other comprehensive income attributable to common shareholders 24,375 49,428   (6,335) 20,525
Comprehensive income (loss) attributable to common shareholders 70,949 71,170   109,718 (198,855)
Guarantor Subsidiaries
         
Schedule of Condensed Consolidating Statement of Operations [Line Items]          
Net revenues 237,949 232,155   740,817 705,703
Cost of goods sold 139,501 130,840   435,937 409,801
Gross profit 98,448 101,315   304,880 295,902
Selling, general and administrative expenses 62,701 61,505   189,193 182,882
Research and development expenses 13,161 13,184   40,250 35,103
Goodwill impairment         331,779
Restructuring and other impairment charges 3,834 1,070   13,112 (580)
(Gain) loss on sales of businesses and assets   (150,310)     (150,310)
Income (loss) from continuing operations before interest and taxes 18,752 175,866   62,325 (102,972)
Interest expense (21,204) (19,488)   (63,348) (59,728)
Interest income (3)     (3) (8)
Income (loss) from continuing operations before taxes 39,959 195,354   125,676 (43,236)
Taxes (benefit) on income (loss) from continuing operations 14,261 17,739   42,241 34,932
Equity in net income of consolidated subsidiaries 48,367 21,946   114,116 100,706
Income (loss) from continuing operations 74,065 199,561   197,551 22,538
Operating income (loss) from discontinued operations   258     (9,171)
Taxes (benefit) on income (loss) from discontinued operations (170) 2,649   (170) (935)
Income (loss) from discontinued operations 170 (2,391)   (170) (8,236)
Net income (loss) 74,235 197,170   197,721 14,302
Net income (loss) attributable to common shareholders 74,235 197,170   197,721 14,302
Other comprehensive income attributable to common shareholders 30,034 50,393   (3,316) 7,136
Comprehensive income (loss) attributable to common shareholders 104,269 247,563   194,405 21,438
Non-Guarantor Subsidiaries
         
Schedule of Condensed Consolidating Statement of Operations [Line Items]          
Net revenues 238,254 196,675   708,206 606,381
Cost of goods sold 130,825 115,381   398,720 349,003
Gross profit 107,429 81,294   309,486 257,378
Selling, general and administrative expenses 38,167 42,030   123,257 109,861
Research and development expenses 2,477 1,576   6,919 4,912
Goodwill impairment         349
Restructuring and other impairment charges 2,422 18   15,265 664
(Gain) loss on sales of businesses and assets         (332)
Income (loss) from continuing operations before interest and taxes 64,363 37,670   164,045 141,924
Interest expense 1,660 1,876   5,232 5,466
Interest income (144) (233)   (455) (956)
Income (loss) from continuing operations before taxes 62,847 36,027   159,268 137,414
Taxes (benefit) on income (loss) from continuing operations 9,962 6,811   30,701 21,306
Equity in net income of consolidated subsidiaries 319     319  
Income (loss) from continuing operations 53,204 29,216   128,886 116,108
Operating income (loss) from discontinued operations (326)     42 2,400
Taxes (benefit) on income (loss) from discontinued operations 156 (266)   246 (95)
Income (loss) from discontinued operations (482) 266   (204) 2,495
Net income (loss) 52,722 29,482   128,682 118,603
Less: Income from continuing operations attributable to noncontrolling interests 234 188   629 701
Net income (loss) attributable to common shareholders 52,488 29,294   128,053 117,902
Other comprehensive income attributable to common shareholders 21,442 41,277   (5,930) 6,510
Comprehensive income (loss) attributable to common shareholders 73,930 70,571   122,123 124,412
Eliminations
         
Schedule of Condensed Consolidating Statement of Operations [Line Items]          
Net revenues (62,407) (60,776)   (203,291) (180,131)
Cost of goods sold (60,522) (58,734)   (202,927) (175,896)
Gross profit (1,885) (2,042)   (364) (4,235)
Selling, general and administrative expenses 272 229   66 539
(Gain) loss on sales of businesses and assets   150,309     266,503
Income (loss) from continuing operations before interest and taxes (2,157) (152,580)   (430) (271,277)
Income (loss) from continuing operations before taxes (2,157) (152,580)   (430) (271,277)
Taxes (benefit) on income (loss) from continuing operations (568) (689)   208 (1,592)
Equity in net income of consolidated subsidiaries (125,134) (74,573)   (325,136) 137,481
Income (loss) from continuing operations (126,723) (226,464)   (325,774) (132,204)
Net income (loss) (126,723) (226,464)   (325,774) (132,204)
Net income (loss) attributable to common shareholders (126,723) (226,464)   (325,774) (132,204)
Other comprehensive income attributable to common shareholders (51,476) (91,670)   9,246 (13,646)
Comprehensive income (loss) attributable to common shareholders $ (178,199) $ (318,134)   $ (316,528) $ (145,850)
[1] The provision for income taxes for the three months ended September 29, 2013 was impacted favorably by the realization of a tax benefit resulting from the expiration of statutes of limitation for a U.S. matter.